Improved Long-Term Survival After Esophagectomy for Esophageal Cancer: Influence of Epidemiologic Shift and Neoadjuvant Therapy

Journal of Gastrointestinal Surgery

Volumn 17, Issue 7, 2013, Pages 1193-1201

  Makowiec, Frank ^a   Baier, Peter ^a   Kulemann, Birte ^a   Marjanovic, Goran ^a   Bronsert, Peter ^a   Zirlik, Katja ^a   Henke, Michael ^a   Hopt, Ulrich Theodor ^a   Hoeppner, Jens ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chemoradiation; Chemotherapy; Esophageal cancer; Esophagectomy; Surgery; Survival

Indexed keywords

EID: 84878766867     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2212-7     Document Type: Article

References (25)

1. Eloubeidi MA, Mason AC, Desmond RA et al. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 2003; 98: 1627-1633.
2. Alibakhshi A, Aminian A, Mirsharifi R, Jahangiri Y, Dashti H, Karimian F. The effect of age on the outcome of esophageal cancer surgery. Ann Thorac Med 2009; 4: 71-74.
3. Ruol A, Portale G, Zaninotto G, et al. Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg 2007; 133: 1186-1192.
4. Internullo E, Moons J, Nafteux P, et al. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Eur J Cardiothorac Surg 2008; 33: 1096-1104.
5. Lee RB, Miller JI (1997). Esophagectomy for cancer. Surg Clin North Am 77(5): 1169-1196.
6. Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72(1): 306-13.
7. Law S, Kwong DL, Kwok KF, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238: 339-347; discussion 347-8.
8. Stein HJ, von Rahden BH, Siewert JR. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg. 2005;390: 280-5.
9. Hofstetter W, Swisher SG, Correa AM et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236: 376-85.
10. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23): 2241-52.
11. Naunheim KS, Petruska P, Roy TS, et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg. 1992;103(5): 887-892.
12. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1): 11-20.
13. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11): 2680-6.
14. Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009;144(3): 247-54.
15. Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202(4): 588-96;.
16. Walther C, Zilling T, Perfekt R, Möller T. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997. Eur J Surg. 2001;167(10): 748-57.
17. Bosetti C, Levi F, Ferlay J, et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2008;122(5): 1118-29.
18. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1, 000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234(3): 360-7; discussion 368-9.
19. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337(3): 161-167.
20. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998; 339(27): 1979-1984.
21. Burmeister BH, Smithers B, Gebski V, et al.; Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the esophagus: a randomized controlled phase III trial. Lancet Oncol. 2005;6(9): 659-668.
22. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients. J Clin Oncol. 2001;19(2): 305-13.
23. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335(7): 462-467.
24. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet. 2002;359(9319): 1727-1733.
25. van Hagen P, Hulshof MC, van Lanschot JJ, et al.; Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22): 2074-84.